𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis

✍ Scribed by Hishitani, Y; Ogata, A; Shima, Y; Hirano, T; Ebina, K; Kunugiza, Y; Shi, K; Narazaki, M; Hagihara, K; Tomita, T; Yoshikawa, H; Tanaka, T; Kumanogoh, A

Book ID
120225120
Publisher
Informa plc
Year
2013
Tongue
English
Weight
248 KB
Volume
42
Category
Article
ISSN
0300-9742

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of drug retention rates and c
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis
✍ Pan, Sophie Martin Du ;Dehler, Silvia ;Ciurea, Adrian ;Ziswiler, Hans-Rudolf ;Ga πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

## Abstract ## Objective Tumor necrosis factor (TNF) inhibitors have revolutionized the treatment of severe rheumatoid arthritis (RA), yet drug discontinuation is common. The aim of this study was to compare treatment retention rates and specific causes of anti‐TNF discontinuation in a population‐